PeptidePedia The community reference

Contributions of LotTraceLuka

User contributions·47 logged edits·page 1 of 1

Contributions by LotTraceLuka, newest first. This list covers edits recorded in the site's change log; the editor's lifetime total of 6,588 edits includes activity predating the current log.

  1. 18:00, 26 Jul 2026 (diff | hist) Thermo Fisher Scientific (China) 8,353 +1,366 correct the regional-warehouse list — six sites, not five
  2. 02:24, 13 Jul 2026 (diff | hist) Qingdao Sigma Chemical 15,457 +2 expand the product-scope row in the infobox
  3. 11:20, 21 Jun 2026 (diff | hist) Talk:Preparative HPLC purification 674 +142 /* Pooling decisions */ new section
  4. 15:25, 18 Jun 2026 (diff | hist) Talk:Lot traceability 885 +124 /* Consolidated shipments */ reply
  5. 17:26, 13 Jun 2026 (diff | hist) Guangzhou JEEP Biotechnology 15,452 ±0 split §Operations from §Product range
  6. 14:49, 30 May 2026 (diff | hist) Peptide aggregation 5,516 ±0 space between number and unit per PP:MOS
  7. 15:18, 30 Mar 2026 (diff | hist) GenScript Peptides 17,613 ±0 add the minimum order quantity for custom synthesis
  8. 13:40, 28 Feb 2026 (diff | hist) Talk:Repackaging 611 +110 /* Retaining the original identifier */ reply
  9. 09:45, 3 Feb 2026 (diff | hist) Talk:Lot traceability 400 +219 /* A lot is a procedural object */ new section
  10. 04:34, 1 Feb 2026 (diff | hist) Wuhan Wansheng Biotechnology 15,849 ±0 state what the certificate supplied with orders carries
  11. 17:03, 30 Jan 2026 (diff | hist) Bachem Holding (Suzhou) 15,124 ±0 m close an unbalanced quotation mark
  12. 20:35, 22 Dec 2025 (diff | hist) Albumin binding half-life extension 6,399 ±0 ce
  13. 13:21, 2 Dec 2025 (diff | hist) Talk:Xi'an Mokemei Biotechnology 611 +300 /* Should the lot-identifier check be described on every supplier article? */ reply
  14. 12:30, 26 Nov 2025 (diff | hist) Bachem Holding (Suzhou) 14,904 ±0 m rm the adjective — an organisation article describes, it does not praise
  15. 09:52, 23 Nov 2025 (diff | hist) Counterfeit peptide 5,488 ±0 m give the fields a compendially-complete certificate would carry
  16. 12:32, 21 Nov 2025 (diff | hist) Certificate of analysis 10,014 ±0 rm the aggregate pass-rate figure; the denominator is not knowable
  17. 16:54, 15 Oct 2025 (diff | hist) WuXi TIDES 16,214 ±0 add the catalogue size and label it self-reported
  18. 02:01, 9 Oct 2025 (diff | hist) Chain of custody 5,157 ±0 rm the inference from one report to a supplier
  19. 04:26, 28 Sep 2025 (diff | hist) GenScript Peptides 6,349 ±0 rm the comparison with another supplier; there is no common basis for it
  20. 22:32, 21 Sep 2025 (diff | hist) Blind sampling 8,193 ±0 rm the inference from one report to a supplier
  21. 12:41, 26 Aug 2025 (diff | hist) Blind sampling 8,193 +326 expand §What blinding is for
  22. 14:05, 23 Aug 2025 (diff | hist) Shenzhen Hybio Pharmaceutical 2,847 ±0 attribute the capability claim to the organisation's own material
  23. 20:39, 8 Aug 2025 (diff | hist) Cost per milligram 4,027 ±0 m rm the telehealth provider name; the article describes the model, not the vendors
  24. 08:55, 7 Aug 2025 (diff | hist) Zhuhai Kerui Biotechnology 6,748 +1,156 state what the certificate supplied with orders carries
  25. 20:27, 17 Jul 2025 (diff | hist) Amylin receptor agonist 4,965 ±0 fix the anchor on an internal link
  26. 12:13, 13 Jun 2025 (diff | hist) Trifluoroacetate counterion 3,918 +19 space between number and unit per PP:MOS
  27. 10:41, 30 May 2025 (diff | hist) Purity claim inflation 4,595 ±0 state that the sample was not drawn blind, so it represents the vial and not the lot
  28. 23:54, 9 Apr 2025 (diff | hist) Shanghai Wibson Biotechnology 6,383 +722 m attribute the capability claim to the organisation's own material
  29. 15:51, 31 Mar 2025 (diff | hist) Batch number 3,708 ±0 expand §Assignment
  30. 12:11, 30 Mar 2025 (diff | hist) GL Biochem (Shanghai) 12,967 +1,223 attribute the documentation description to the purchaser reports it comes from
  31. 15:13, 23 Mar 2025 (diff | hist) Blind sampling 6,780 ±0 m add the cross-link to the traceability article
  32. 09:28, 11 Mar 2025 (diff | hist) Talk:Peptide supply chain 537 +187 /* Repackaging: how common is it really? */ new section
  33. 22:43, 12 Feb 2025 (diff | hist) Liraglutide 4,295 ±0 m add the peptide length to the infobox
  34. 17:23, 5 Jan 2025 (diff | hist) Bachem Holding (Suzhou) 6,099 +201 British spelling per PP:MOS
  35. 02:34, 2 Jan 2025 (diff | hist) Purity claim inflation 3,067 +149 rm the aggregate pass-rate figure; the denominator is not knowable
  36. 23:17, 12 Dec 2024 (diff | hist) GL Biochem (Shanghai) 8,549 ±0 add the outbound storefront link, marked nofollow and sponsored per the external-links convention
  37. 23:07, 1 Dec 2024 (diff | hist) WuXi TIDES 7,453 +336 add the see-also to the certificate-of-analysis article
  38. 18:37, 1 Dec 2024 (diff | hist) Peptide supply chain 3,807 +268 rm the vendor-specific packaging detail; not general enough for the article
  39. 03:32, 24 Nov 2024 (diff | hist) Lixisenatide 2,302 +255 m state which salt form the mass in the infobox refers to
  40. 09:42, 17 Nov 2024 (diff | hist) Shanghai Sigma-Audley New Material Technology 2,709 +363 state what the certificate supplied with orders carries
  41. 02:42, 3 Nov 2024 (diff | hist) Tianjin Finder Chemical 1,688 ±0 m rm a duplicated category
  42. 13:43, 22 Oct 2024 (diff | hist) ChinaPeptides 1,731 +38 m expand §Product range
  43. 21:12, 9 Oct 2024 (diff | hist) FLOW trial 1,950 +752 m correct the endpoint hierarchy — that was a secondary endpoint
  44. 11:58, 21 Sep 2024 (diff | hist) Blind sampling 2,941 ±0 m state the date range the submitted set covers
  45. 09:00, 13 Sep 2024 (diff | hist) Chain of custody 2,414 +2,414 N create article — testing stub
  46. 17:54, 20 Aug 2024 (diff | hist) Reference standard 2,461 +464 add the note on co-elution and what it hides
  47. 20:18, 14 Jul 2024 (diff | hist) GL Biochem (Shanghai) 2,837 ±0 expand the product-scope row in the infobox